Stock listing

Armata Pharmaceuticals, Inc.

Selected listing: TG1N · DUS · EUR · DE

Armata Pharmaceuticals, Inc. (Dusseldorf:TG1N), Health Technology. Latest release Sep 23, 2026: Armata Pharmaceuticals Receives $3.7 Million in Additional…

TG1N:DUSEURDEUpdated October 3, 2026

Ticker: Dusseldorf:TG1N
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: Dusseldorf
Currency: EUR

About Armata Pharmaceuticals, Inc.

Armata Pharmaceuticals, Inc. (ticker: ARMP) is a public company based in the United States, focusing on innovative therapies for bacterial infections. The company is committed to developing solutions that improve patient outcomes and combat antibiotic resistance.

Latest news from Armata Pharmaceuticals, Inc.

Armata Pharmaceuticals Receives $3.7 Million in Additional Non-Dilutive Funding from U.S. Department of War to Support Advancement of AP-SA02 Phase 3 Development

September 23, 2026

Armata Pharmaceuticals to Present Data at ISSSI 2026 Showing Defined Genetic Diversity in AP-SA02 May Enhance Killing of Certain Staphylococcus aureus Clinical Isolates

September 21, 2026

Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02

September 14, 2026

Armata Pharmaceuticals to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

September 10, 2026

Armata Pharmaceuticals Announces New Publication That Advances Understanding of Phage Biology to Support Development of Next-Generation Antibacterials

September 3, 2026

All Armata Pharmaceuticals, Inc. news →

Research Armata Pharmaceuticals, Inc.

Armata Pharmaceuticals, Inc. company profile

View the public company page for Armata Pharmaceuticals, Inc. on 6ix.

Armata Pharmaceuticals, Inc. news

Read company news and market updates connected to Armata Pharmaceuticals, Inc..

Armata Pharmaceuticals, Inc. investor events

Find investor webinars, events, and replay context for Armata Pharmaceuticals, Inc..